Oct 30, 2024 · 24m · the-pitch
Will VCs Bet $4M on This Robot Healthcare Startup?
gold bands on the timeline = statements, start to end. Hover to read, click to jump. CC turns on captions
Ryan James pitches Doppel Technologies on The Pitch, seeking $4 million for a telerobotic ultrasound platform that allows remote specialists to conduct live diagnostic scans in underserved rural hospitals. After demonstrating the platform's safety systems, Medicare-backed hospital unit economics, and 510(k) regulatory pathway, Ryan secures investment commitments from Charles Hudson and The Pitch Fund.
How this conversation actually went
Every chapter scored 0–10 on four independent dynamics. Hover any point for the reasoning behind the score. Josh holds 19.6% of the talking time here. How this is scored →
speaking balance: gold is Josh, purple is the guest (3 minute bins)
Ryan firmly rejects Cyan's suggestion to resell French hardware, detailing how its awkward manual assistant requirement ruins sonographer workflow.
Hardest push from Josh ▶ 9:08 Cyan challenges building custom hardwareCyan pushes back directly on Doppel's decision to build hardware rather than white-labeling an already FDA-approved foreign device.
Biggest teaching moment ▶ 15:51 Ryan explains critical access hospital financialsRyan educates Josh on rural hospital economics, explaining that Medicare reimburses critical access hospitals strictly at cost so profit maximization is not their mandate.
Josh holds their own ▶ 12:00 Jesse applies autonomous farming parallelsJesse demonstrates investor domain expertise by breaking down telematic versus autonomous business models from his firm's agricultural robotics portfolio.
the scores for every segment, with the reasoning behind each
| Chapter | Topic | Josh as informed peer | Guest teaching | Guest disagreement | Josh pushing back | Why |
|---|---|---|---|---|---|---|
| Introducing Doppel and the Promise of Remote Medical Hardware | 2 | 3 | 1 | 1 | Josh opens the episode detailing the challenges of hardware startups and introduces Ryan James. Ryan delivers his pitch uninterrupted, highlighting the mortality disparity in rural healthcare and Doppel's telerobotic solution. | |
| Demonstrating Robotic Ultrasound Mechanics and Safety Systems | 2 | 4 | 1 | 1 | The panel asks clarifying questions regarding hardware ergonomics and safety mechanisms. Ryan explains their haptic pressure feedback algorithms and past successful trials on animal subjects. | |
| Analyzing Doppel's Moat and Regulatory Strategy | 4 | 5 | 1 | 3 | Josh asks whether Doppel is using custom or off-the-shelf robotics hardware. Ryan details their use of Universal Robotics arms and explains their fast-track 510(k) FDA predicate strategy based on a French competitor. | |
| Evaluating Market Differentiation and Hospital Economics | 4 | 6 | 2 | 4 | Cyan pushes Ryan on why they don't simply resell the French competitor's device instead of building hardware. Ryan explains the severe ergonomic flaws in the competitor's system and explains Medicare reimbursement models for rural hospitals. | |
| Exploring Mobile Applications and Sonographer Lifestyle Benefits | 3 | 4 | 1 | 2 | Cyan and Jesse suggest alternative business models like mobile units and draw parallels to autonomous farming tractors. Ryan explains the core lifestyle benefit for remote sonographers who currently endure extensive travel. | |
| Reviewing Capital History and Rural Hospital Priorities | 3 | 6 | 1 | 3 | Josh expresses surprise that critical access hospitals are not motivated by maximizing profit. Ryan explains the governmental cost-reimbursement model that allows these non-profit rural facilities to focus strictly on community coverage. | |
| Investor Deliberations and Charles Hudson's Investment Offer | 4 | 2 | 1 | 2 | Jesse passes due to sector misalignment while Cyan requests follow-up diligence. Charles makes a $25k commitment, and Josh joins in with a $25k-$50k syndicate check. | |
| Post-Pitch Investor Analysis and Deal Reflections | 4 | 0 | 0 | 0 | In post-pitch deliberations without the founder, the investors reflect positively on the market timing for medical robotics and compliment Ryan's founder presence. |